Blue Bird's revenue was $313.9 million, which decreased slightly compared to the $317.7 million from the previous year. Read ...

Cannes is back: The 78th French film festival returns May 13-24 with a wave of world premieres that will set the tone for the ...

Blue Bird is well-positioned to benefit from long-term tailwinds for the electric bus industry, despite regulatory headwinds.

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

It’s a bird, it’s a plane, it’s the future!Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall Street ...

Ayrmid has offered to buy bluebird for an upfront cash payment of $4.50 a share and a one-time contingent value right of $6.84 a share, payable upon achievement of a net sales milestone, said ...

In a report released on March 28, Gena Wang from Barclays maintained a Buy rating on Bluebird Bio (BLUE – Research Report), with a price target ...

This shot of a pair of courting crab spiders, taken by nature photographer Sandip Guha in Shiliguri, India, highlights the ...

The most important Republican in New Jersey's race for governor this year might well be a part-time resident who burnished ...

An initiative in Zambia is showing that a profit-seeking company can help rural farmers battling extreme weather breed chickens that lay more eggs.

The new bid surpasses an offer SK Capital and Carlyle Group made last month for the gene therapy developer, which Bluebird’s ...

Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.